Standard BioTools Inc.NASDAQ: LAB

Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

· Issued by Standard BioTools Inc. via GlobeNewswire

Summary by 6ix AI

Standard BioTools Inc., a life science tools company, will publish its second quarter 2026 financial results on Wednesday, August 5, 2026, after U.S. market close.

Key details

  • Standard BioTools Inc. trades on the Nasdaq stock exchange under the symbol LAB.

6ix AI wrote this summary from the release below and checked it against the release.

BOSTON, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish its second quarter 2026 financial results on Wednesday, August 5, 2026, after U.S. market close.

About Standard BioTools Inc.

Standard BioTools, Inc. (NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster.

For Research Use Only. Not for use in diagnostic procedures.

Limited Use Label License and other terms may apply: standardbio.com/legal/terms-and-conditions/.
Patent and License Information: standardbio.com/legal/notices.

Trademarks: standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2026 Standard BioTools Inc. (f.k.a. Fluidigm Corporation). All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com

Standard BioTools Inc. on 6ix

Story so far

Earlier from Standard BioTools

Later from Standard BioTools

All Standard BioTools news releases